Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies
Crossref DOI link: https://doi.org/10.1007/s40261-016-0420-0
Published Online: 2016-06-09
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Roberts, Tracey
Kokai-Kun, John F.
Coughlin, Olivia
Lopez, Barbara Valero
Whalen, Heidi
Bristol, J. Andrew
Hubert, Steven
Longstreth, James
Lasseter, Kenneth
Sliman, Joseph
License valid from 2016-06-09